Statins as a newly recognized type of immunomodulator.

Kwak, Brenda, Mulhaupt, Flore, Myit, Samir, Mach, François·2000·Nature Medicine

Cited by (1,001)

Items 501–600 of 1,001

  1. Simvastatin affects cell motility and actin cytoskeleton distribution of microglia
    Hedwich F. Kuipers, Angelika Rappert, A. Mieke Mommaas, Elise S. van Haastert, Paul van der Valk, H. W. G. M. Boddeke, Knut P. H. Biber, Peter J. van den Elsen · 2005 · Glia
  2. Inhibition Of Proliferation And Signalling Mechanisms In Human Lymphocytes By Fluvastatin
    Dianne Z. Hillyard, Angus J.M. Cameron, Alan McIntyre, Mark Hadden, Hilary E. Marshall, Nicola Johnston, Alan G. Jardine · 2002 · Clinical and Experimental Pharmacology and Physiology
  3. Effects of pravastatin in murine collagen-induced arthritis
    Toshiaki Yamagata, Koji Kinoshita, Yuji Nozaki, Masafumi Sugiyama, Shinya Ikoma, Masanori Funauchi · 2006 · Rheumatology International
  4. Statins inhibit lymphocyte homing to peripheral lymph nodes
    René Schramm, Michael Dieter Menger, Yves Harder, Rudolf Schmits, Oliver Adam, Gabriele Weitz‐Schmidt, Hans‐Joachim Schäfers · 2006 · Immunology
  5. Statins’ immunomodulatory potential against Th17 cell-mediated autoimmune response
    Xin Zhang, Silva Markovic‐Plese · 2008 · Immunologic Research
  6. Systemic effects of chronic obstructive pulmonary disease
    David M.G. Halpin · 2007 · Expert Review of Respiratory Medicine
  7. Lymphocyte Function-Associated Antigen-1 Blockade by Statins: Molecular Basis and Biological Relevance
    Gabriele Weitz‐Schmidt · 2003 · Endothelium
  8. A statin‐based inhibitor of lymphocyte function antigen‐1 protects against ischemia/reperfusion‐induced leukocyte adhesion in the colon
    Min Wan, René Schramm, Daniel Klintman, Karl Welzenbach, Gabriele Weitz‐Schmidt, Henrik Thorlacius · 2003 · British Journal of Pharmacology
  9. Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome
    Renáta Laczik, Péter Szodoray, K. Veres, Edit Szomják, István Csípő, Sándor Sipka, Yehuda Shoenfeld, Zoltán Szekanecz, Pál Soltész · 2011 · Lupus
  10. Understanding and Controlling Chronic Immune Activation in the HIV-Infected Patients Suppressed on Combination Antiretroviral Therapy
    Babafemi Taiwo, Luis Barcena, Randall Tressler · 2012 · Current HIV/AIDS Reports
  11. The Role of Environmental Factors in the Etiology of Lymphoma
    Victoria Susana Blinder, Susan Gross Fisher · 2008 · Cancer Investigation
  12. Current Status of Renal Transplantation
    Chris J. Callaghan, J. Andrew Bradley · 2006 · Humana Press eBooks
  13. Atorvastatin attenuates the antinociceptive tolerance of morphine via nitric oxide dependent pathway in male mice
    Mahsa Hassanipour, Hossein Amini-Khoei, Hamed Shafaroodi, Armin Shirzadian, Nastaran Rahimi, Muhammad Imran Khan, Seyed Mahdi Rezayat, Ahmad Reza Dehpour · 2016 · Brain Research Bulletin
  14. Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodies
    Toshiyuki Watanabe, Kenji Oku, Olga Amengual, Ryo Hisada, Koichiro Ohmura, I. Nakagawa, Haruki Shida, Toshiyuki Bohgaki, Tetsuya Horita, Shinsuke Yasuda et al. · 2017 · Lupus
  15. Statins and autoimmune diseases
    Victor S. Gurevich, Ora Shovman, L Slutzky, Pier Luigi Meroni, Yehuda Shoenfeld · 2004 · Autoimmunity Reviews
  16. A review of the effects of statins in systemic sclerosis
    Karim Ladak, Janet Elizabeth Pope · 2015 · Seminars in Arthritis and Rheumatism
  17. Role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors, angiotensin-converting enzyme inhibitors, cyclooxygenase-2 inhibitors, and aspirin in anti-inflammatory and immunomodulatory treatment of cardiovascular diseases
    Bernhard Schieffer, Helmut Drexler · 2003 · The American Journal of Cardiology
  18. Applications of statins in cardiothoracic surgery: more than just lipid-lowering
    Kosmas I. Paraskevas · 2008 · European Journal of Cardio-Thoracic Surgery
  19. Potential metabolic consequences of statins in sepsis*
    David A. Brealey, Mervyn Singer, Marius Terblanche · 2011 · Critical Care Medicine
  20. Clinical Implications of Intracoronary Imaging in Cardiac Allograft Vasculopathy
    Raviteja Reddy Guddeti, Yoshiki Matsuo, Yasushi Matsuzawa, Tatsuo Aoki, Lilach O. Lerman, Sudhir S. Kushwaha, Amir Lerman · 2015 · Circulation Cardiovascular Imaging
  21. Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model
    Jean-Baptiste Souraud, Sébastien Briolant, Jérôme Dormoi, Joel Mosnier, Hélène Savini, Eric Baret, Rémy Amalvict, Raoulin Soulard, Christophe Rogier, Bruno Pradines · 2012 · Malaria Journal
  22. Simvastatin Attenuates Formalin-Induced Nociceptive Behaviors by Inhibiting Microglial RhoA and p38 MAPK Activation
    Xin-Yi Chen, Kai Li, Alan R. Light, Kai‐Yuan Fu · 2013 · Journal of Pain
  23. Atorvastatin Therapy Modulates Telomerase Activity in Patients Free of Atherosclerotic Cardiovascular Diseases
    Irina Dmitrievna Strazhesko, О. Н. Ткачева, Dariga Uaydinichna Akasheva, Е. N. Dudinskaya, Плохова Екатерина Владимировна, V. S. Pykhtina, Кругликова Анна Сергеевна, Н. В. Кокшагина, Н. В. Шарашкина, Агальцов Михаил Викторович et al. · 2016 · Frontiers in Pharmacology
  24. Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension
    Zahra Sepehri, Mohammad Masoumi, Nazanin Ebrahimi, Zohre Kiani, Ali Akbar Nasiri, Farhad Kohan, Mahmood Sheikh Fathollahi, Mohammad Kazemi Arababadi, Gholamreza Asadikaram · 2016 · PLoS ONE
  25. Statin therapy in patients with community-acquired pneumonia
    Frances Susanna Grudzinska, Davinder P. S. Dosanjh, Dhruv Parekh, Rachel C. A. Dancer, Jaimin Patel, Peter Nightingale, Georgia Walton, Elizabeth Sapey, DAVID R. THICKETT · 2017 · Clinical Medicine
  26. Drug Insight: immunomodulatory effects of statins—potential benefits for renal patients?
    Sabine Steffens, François Mach · 2006 · Nature Reviews Nephrology
  27. Anti-Inflammatory and Immunomodulating Properties of Statins: An Additional Tool for the Therapeutic Approach of Systemic Autoimmune Diseases?
    Pier Luigi Meroni, Cristina Luzzana, Donatella Ventura · 2002 · Clinical Reviews in Allergy & Immunology
  28. Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients
    Steven E. Lipshultz, Stacy D. Fisher, Wyman W. Lai, Tracie L. Miller · 2003 · AIDS
  29. Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis
    Takemi Tanaka, Cynthia M. Porter, Judith A. Horvath‐Arcidiacono, Eda T. Bloom · 2006 · International Immunology
  30. The effects of atorvastatin in experimental autoimmune uveitis
    P. B. Thomas · 2005 · British Journal of Ophthalmology
  31. Attenuation of airway inflammation by simvastatin and the implications for asthma treatment: is the jury still out?
    Jingnan Liu, Dong‐Hyeon Suh, Eun‐Mi Yang, Seung-Ihm Lee, Hae‐Sim Park, Yoo Seob Shin · 2014 · Experimental & Molecular Medicine
  32. Effect of Atorvastatin on Wound Healing in Rats
    Vanessa Ferraz Suzuki Banhesse, Flávia Figueiredo Azevedo, ELIANA PEREIRA DE ARAUJO, Maria Esméria Corezola do Amaral, Andréa M. Caricilli, Mário J.A. Saad, Maria Helena Melo Lima · 2014 · Biological Research For Nursing
  33. Statins as Immunomodulators in Systemic Sclerosis
    A. Abou‐Raya, S. Abou‐Raya, Madihah Helmii · 2007 · Annals of the New York Academy of Sciences
  34. Immunopathogenesis of atherosclerosis
    Burkhard Ludewig, Philippe Krebs, Elke Scandella · 2004 · Journal of Leukocyte Biology
  35. Pharmacological inhibitors of the mevalonate pathway activate pro-IL-1 processing and IL-1 release by human monocytes
    Benoit Massonnet, Sylvain Normand, Reinhard Moschitz, Adriana Delwail, Laure Favot, Martine Garcia, Nicolas Bourmeyster, Laurence Cuisset, Gilles Grateau, Franck Morel et al. · 2009 · European Cytokine Network
  36. Evidence To Support Continuation of Statin Therapy in Patients with Staphylococcus aureus Bacteremia
    Aisling R. Caffrey, Tristan T. Timbrook, Eunsun Noh, George Sakoulas, Steven M. Opal, Victor Nizet, Kerry L. LaPlante · 2017 · Antimicrobial Agents and Chemotherapy
  37. Management of Invasive Infections in Diabetes Mellitus: A Comprehensive Review
    Anjum Khanam, Gavirangappa Hithamani, Naveen Jayapala, Seetur Radhakrishna Pradeep, Susmita Barman, Krishnapura Srinivasan · 2023 · Biologics
  38. Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration
    Mathias Buttmann, Alexander Lorenz, Andreas Weishaupt, Peter Rieckmann · 2007 · Journal of Neurochemistry
  39. A Prospective Study of Statin Use and Poststroke Depression
    Jae‐Min Kim, Robert J. Stewart, Hee‐Ju Kang, Kyung‐Yeol Bae, Sung‐Wan Kim, Il‐Seon Shin, Joon‐Tae Kim, Man‐Seok Park, Ki-Hyun Cho, Jin‐Sang Yoon · 2013 · Journal of Clinical Psychopharmacology
  40. Treatment of Dyslipidemia in Allogeneic Hematopoietic Stem Cell Transplant Patients
    Bernard Lawrence Marini, Sung Won Choi, Craig Alan Byersdorfer, Simon M. Cronin, David G. Frame · 2014 · Transplantation and Cellular Therapy
  41. Fluvastatin inhibits expression of the chemokine MDC/CCL22 induced by interferon‐γ in HaCaT cells, a human keratinocyte cell line
    Xufeng Qi, Dong‐Heui Kim, Yang‐Suk Yoon, Jianhong Li, Dan Jin, Yung‐Chien Teng, Soo‐Ki Kim, Kyu‐Jae Lee · 2009 · British Journal of Pharmacology
  42. The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: Part I
    Annemarie M. Armani, Richard Clinton Becker · 2005 · American Heart Journal
  43. Blood pressure reduction with HMG-CoA reductase inhibitors in renal transplant recipients
    G. V. Ramesh Prasad, Aasia Ahmed, Michelle M. Nash, Jeffrey Steven Zaltzman · 2003 · Kidney International
  44. Use of hydroxy‐methyl‐glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignancies
    Hiroshi Iwata, Keitaro Matsuo, Shigeo Hara, Kengo Takeuchi, Tomonori Aoyama, Naoko Murashige, Yoshinobu Kanda, Shin‐ichiro Mori, Ritsuro Suzuki, Shintaro Tachibana et al. · 2006 · Cancer Science
  45. Do statins offer therapeutic potential in inflammatory arthritis?
    Iain B. McInnes, D W McCarey, Naveed A. Sattar · 2004 · Annals of the Rheumatic Diseases
  46. Randomized clinical trial: Atorvastatin versus placebo in patients with acute exacerbation of mild to moderate ulcerative colitis
    Puneet Dhamija, Debasish Hota, Rakesh K. Kochhar, Atul Sachdev, Amitava Chakrabarti · 2013 · Indian Journal of Gastroenterology
  47. Perioperative pleiotropic statin effects in general surgery
    James Christopher Iannuzzi, Aaron S. Rickles, Kristin N. Kelly, Aaron E. Rusheen, James G. Dolan, Katia Noyes, John R.T. Monson, Fergal J. Fleming · 2013 · Surgery
  48. Topical simvastatin gel as a novel therapeutic modality for palatal donor site wound healing following free gingival graft procedure
    Marwa I. Madi, Abeer Ahmed Kassem · 2017 · Acta Odontologica Scandinavica
  49. Rosuvastatin exerts favourable effects on thrombosis and neointimal growth in a mouse model of endothelial injury
    Katrin Schäfer, Kilian Kaiser, Stavros Konstantinides · 2004 · Thrombosis and Haemostasis
  50. Effects of statins on adhesion molecule expression in endothelial cells
    Y. Dimitrova, Sylvie Dunoyer-Geindre, Guido Reber, François Mach, Egbert K. O. Kruithof, Philippe de Moerloose · 2003 · Journal of Thrombosis and Haemostasis
  51. Evaluation of Atorvastatin for the Treatment of Patients With Asthma: A Double-Blind Randomized Clinical Trial
    Abdollatif Moini, Ghasem Azimi, Abdolhay Farivar · 2012 · Allergy Asthma and Immunology Research
  52. IK cytokine ameliorates the progression of lupus nephritis in MRL/lprmice
    Masatake Muraoka, Hitoshi Hasegawa, Masashi Kohno, Atsushi Inoue, Tatsuhiko Miyazaki, Miho Terada, Masato Nose, Masaki Yasukawa · 2006 · Arthritis & Rheumatism
  53. Novel targets and new potential: developments in the treatment of inflammation in chronic kidney disease
    Csaba Pal Kovesdy, Kamyar Kalantar‐Zadeh · 2008 · Expert Opinion on Investigational Drugs
  54. Geranylgeranyl transferase inhibition stimulates antimelanoma immune response through MHC class I and costimulatory molecule expression
    Anne‐Françoise Tilkin‐Mariamé, Carine Cormary, Nathalie Ferro, Guillaume Sarrabayrouse, Isabelle Lajoie‐Mazenc, Jean‐Charles Faye, Gilles Favre · 2005 · The FASEB Journal
  55. Simvastatin protection against acute immune-mediated glomerulonephritis in mice
    MABEL BARBARO CHRISTENSEN, A.W. Su, R.W. Snyder, Andres J. Greco, Joshua H. Lipschutz, Michael P. Madaio · 2006 · Kidney International
  56. Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats
    Weimin Li, Wei Liu, Cheng Gao, Baoguo Zhou · 2006 · Immunology and Cell Biology
  57. Dual‐Function Nanoscale Coordination Polymer Nanoparticles for Targeted Diagnosis and Therapeutic Delivery in Atherosclerosis
    Yuanzhe Lin, Jingjing Liu, Suet Yen Chong, Hui Jun Ting, Xichuan Tang, Liqiang Yang, Sitong Zhang, Xinyi Qi, Peng Pei, Zhigao Yi et al. · 2024 · Small
  58. Simvastatin inhibits pro-inflammatory mediators through induction of heme oxygenase-1 expression in lipopolysaccharide-stimulated RAW264.7 macrophages
    Pak‐On Leung, Sue‐Hong Wang, Sheng-Hua Lu, Wen‐Hsiang Chou, Chia‐Yang Shiau, Tz‐Chong Chou · 2011 · Toxicology Letters
  59. Inhibition of Interferon-beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins
    Xuan Feng, Diana Siao Cheng Han, Bharat K Kilaru, Beverly S. Franek, Timothy B. Niewold, Anthony T. Reder · 2012 · Archives of Neurology
  60. Fluvastatin Suppresses Mast Cell and Basophil IgE Responses: Genotype-Dependent Effects
    Elizabeth Motunrayo Kolawole, Jamie Josephine Avila McLeod, Victor S Ndaw, Daniel Abebayehu, Brian O. Barnstein, Travis Faber, Andrew J Spence, Marcela T Taruselli, Anuya R Paranjape, Tamara T. Haque et al. · 2016 · The Journal of Immunology
  61. Statins reduce relapse rate in Takayasu arteritis
    Oh Chan Kwon, Ji Seon Oh, Min‐Chan Park, Seokchan Hong, Chang‐Keun Lee, Bin Yoo, Yong‐Gil Kim · 2019 · International Journal of Cardiology
  62. Immunometabolic cross-talk in the inflamed heart
    Federica M. Marelli‐Berg, Dunja Aksentijević · 2019 · Cell Stress
  63. Simvastatin treatment improves survival in a murine model of burn sepsis: Role of interleukin 6
    David C. Beffa, Alan J. Fischman, Shawn P. Fagan, Victoria F. Hamrahi, Kasie W. Paul, Masao Kaneki, Yong‐Ming Yu, Ronald Gary Tompkins, Edward A. Carter · 2010 · Burns
  64. The cardioprotective effects of statins
    Jean Davignon · 2004 · Current Atherosclerosis Reports
  65. Statins and the vasculopathy of systemic sclerosis: Potential therapeutic agents?
    Chris T. Derk, Sergio A. Jiménez · 2005 · Autoimmunity Reviews
  66. Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3
    Yasamin Majlesi, Puchit Samorapoompichit, Alexander W. Hauswirth, Gerit-Holger Schernthaner, Minoo Ghannadan, Mehrdad Baghestanian, Abdolreza Rezaie-Majd, Rudolf Valenta, Wolfgang R. Sperr, Hans‐Jörg Bühring et al. · 2003 · Journal of Leukocyte Biology
  67. HMG-CoA Reductase Inhibitors Are Associated with Decreased Serum Neopterin Levels in Stable Coronary Artery Disease
    Roland B. Walter, Dietmar Fuchs, Günter Weiß, Thomas R. Walter, Walter Hans Reinhart · 2003 · Clinical Chemistry and Laboratory Medicine (CCLM)
  68. Increased Expression of Plasminogen Activator Inhibitor-1 by Mediators of the Acute Phase Response: a Potential Progenitor of Vasculopathy in Hypertensives
    Jie DONG, Satoshi Fujii, Daisuke Goto, Tomoo Furumoto, Takeaki Kaneko, Tarkikuz A. ZAMAN, Yukihito Nakai, Tetsuya Mishima, Shogo Imagawa, Akira Kitabatake · 2003 · Hypertension Research
  69. An immunosuppressive effect by synthetic sulfonolipids deduced from sulfonoquinovosyl diacylglycerols of sea urchin
    Yoshitaka Matsumoto, Hiroeki Sahara, Tatsuya Fujita, Kumiko Shimozawa, Mika Takenouchi, Toshihiko Torigoe, Shinya Hanashima, Takeyuki Yamazaki, Shunya Takahashi, Fumio Sugawara et al. · 2002 · Transplantation
  70. Effects of Atorvastatin on Th Polarization in Patients with Acute Myocardial Infarction
    Xiang Chao Cheng, Yu‐Hua Liao, Jinying Zhang, Bin Li, Hongxia Ge, Jing Yuan, Min Wang, Baojun Lu, Ying Liu, Yan Cheng · 2005 · European Journal of Heart Failure
  71. Fluvastatin ameliorates endotoxin induced multiple organ failure in conscious rats
    Chung-Hua Chen, Ru-Ping Lee, Wen-Tien Wu, Kuang‐Wen Liao, Nanly Hsu, Bang‐Gee Hsu · 2007 · Resuscitation
  72. Do Statins Afford Neuroprotection in Patients with Cerebral Ischaemia and Stroke?
    Carl J. Vaughan, Norman Delanty, Craig T. Basson · 2001 · CNS Drugs
  73. Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies
    Heinz Wiendl, Bernd C. Kieseier · 2003 · Expert Opinion on Investigational Drugs
  74. Coronary microvasculopathy in heart transplantation: Consequences and therapeutic implications
    Alessandra Vecchiati, Sara Tellatin, Annalisa Angelini, Sabino Iliceto, Francesco Tona · 2014 · World Journal of Transplantation
  75. HMG-CoA Reductase Inhibitors as Immunomodulators
    Liza Jane Raggatt, Nicola C. Partridge · 2002 · Drugs
  76. Is Statin Exposure Associated with Occurrence or Better Outcome in Giant Cell Arteritis? Results from a French Population-based Study
    G. Pugnet, L. Sailler, Robert Bourrel, Jean‐Louis Montastruc, Maryse Lapeyre‐Mestre · 2014 · The Journal of Rheumatology
  77. Tissue factor regulation and cytokine expression in monocyte–endothelial cell co-cultures
    Eva Lindmark, Agneta Siegbahn · 2002 · Thrombosis Research
  78. Simvastatin Improves Wound Strength after Intestinal Anastomosis in the Rat
    Guldeniz Karadeniz Cakmak, Oktay İrkörücü, Bülent Hamdi Uçan, Arif Emre, Burak Bahadır, C. Demirtas, O. Tascilar, Kemal Karakaya, S. Acikgoz, Gürkan Kertiş et al. · 2009 · Journal of Gastrointestinal Surgery
  79. Effects of simvastatin in abdominal sepsis in rats
    José Luiz de Souza Neto, Irami Araújo-Filho, Amália Cínthia Meneses do Rêgo, Victor A. Dominici, Ítalo Medeiros Azevedo, Eryvaldo Sócrates Tabosa do Egito, José Brandão‐Neto, Aldo Cunha Medeiros · 2006 · Acta Cirúrgica Brasileira
  80. Toll‐like receptor signaling: Common pathways that drive cardiovascular disease and rheumatoid arthritis
    Claudia Gianini Monaco, Niccolò Terrando, Kim S. Midwood · 2010 · Arthritis Care & Research
  81. Rapid proteasomal elimination of 3-hydroxy-3-methylglutaryl-CoA reductase by interferon- γ in primary macrophages requires endogenous 25-hydroxycholesterol synthesis
    Hongjin Lu, Simon J. Talbot, Kevin A. Robertson, Steven Watterson, Thorsten Forster, Douglas J. Roy, Peter Ghazal · 2015 · Steroids
  82. Regulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti‐melanoma immune response
    Guillaume Sarrabayrouse, Christine Pich-Bavastro, Iotefa Teiti, Anne Françoise Tilkin‐Mariame · 2016 · International Journal of Cancer
  83. Potential vascular benefits of statins
    Scott Kinlay · 2005 · The American Journal of Medicine
  84. What causes acute coronary syndromes? Applying Koch's postulates
    Claudia Gianini Monaco, Anthony Mathur, John F. Martin · 2005 · Atherosclerosis
  85. Genomic and proteomic analysis of multiple sclerosis. Opinion.
    W. Robinson, P. Utz, L. Steinman · 2003 · Current Opinion in Immunology
  86. Modifiers of Symptomatic Embolic Risk in Infective Endocarditis
    Anavekar, Nandan S., Schultz, Jason C., De Sa, Daniel D. Correa, Thomas, Justin M., Lahr, Brian D., Tleyjeh, Imad M., Steckelberg, James M., Wilson, Walter R., Baddour, Larry M. · 2011 · Mayo Clinic Proceedings
  87. Tropical cattle methane emissions: the role of natural statins supplementation
    Carlos Alberto Ramírez-Restrepo, Christopher J. O’Neill, Nicolas Lopez-Villalobos, Jagadish Padmanabha, Christopher S. McSweeney · 2014 · Animal Production Science
  88. Statins in chronic kidney disease and kidney transplantation
    Theodoros Ioannis Kassimatis, David J.A. Goldsmith · 2014 · Pharmacological Research
  89. The impact of prior long-term versus short-term statin use on the mortality of bacteraemic patients
    William Nseir, J. Khateeb, O. Abu‐Elheja, Briki Jihad, Nimer Assy · 2011 · Infection
  90. Statins in the intensive care unit
    Marc W. Merx, Christian Weber · 2006 · Current Opinion in Critical Care
  91. Statins inhibit chemotactic interaction between CCL20 and CCR6 in vitro: possible relevance to psoriasis treatment
    Tae‐Gyun Kim, Dashlkhumbe Byamba, Wen Hao Wu, Min‐Geol Lee · 2011 · Experimental Dermatology
  92. Treatment of Alopecia Areata with Simvastatin/Ezetimibe
    Jessica Cervantes, Joaquin Juan Jimenez, Gina M. DelCanto, Antonellá Tosti · 2017 · Journal of Investigative Dermatology Symposium Proceedings
  93. Dual loading of Nigella sativa oil-atorvastatin in chitosan–carboxymethyl cellulose nanogel as a transdermal delivery system
    Fereshteh Bagheri, Sara Darakhshan, Saharnaz Mazloomi, Behrang Shiri Varnamkhasti, Reza Tahvilian · 2021 · Drug Development and Industrial Pharmacy
  94. Simvastatin pretreatment prevents ambient particle-induced lung injury in mice
    Sebastián Ariel Ferraro, Juan Sebastián Yakisich, Francisco T. Gallo, Deborah R. Tasat · 2011 · Inhalation Toxicology
  95. The role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) in modern rheumatology
    Przemysław Jacek Kotyla · 2010 · Therapeutic Advances in Musculoskeletal Disease
  96. The Role of Simvastatin in the Therapeutic Approach of Rheumatoid Arthritis
    Lucia Cojocaru, Andrei Constantin Rusali, Cristina Şuţa, Anca Mihaela Rădulescu, Maria Șuța, Elvira Craiu · 2013 · Autoimmune Diseases
  97. Statin Treatment and Mortality: Propensity Score-Matched Analyses of 2007–2008 and 2009–2010 Laboratory-Confirmed Influenza Hospitalizations
    Matthew R. Laidler, Ann R Thomas, Jan Baumbach, Pam Daily Kirley, James I. Meek, Deborah Aragon, Craig A. Morin, Patricia Ryan, William Schaffner, Shelley M. Zansky et al. · 2015 · Open Forum Infectious Diseases
  98. Cholesterol lowering drug may influence cellular immune response by altering MHC II function
    Koushik Roy, Moumita Ghosh, Tuhin Kumar Pal, Saikat Chakrabarti, Syamal Roy · 2013 · Journal of Lipid Research
  99. Effect of Cardiac Rehabilitation and Statin Treatment on Anti-HSP Antibody Titers in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
    Young‐Oh Shin, Jun-Sang Bae, Jeong‐Beom Lee, Jung-Kyu Kim, Young‐Joo Kim, Chul Kim, Jaeki Ahn, In-Keol Bang, Byoung Kwon Lee, Timothy Othman et al. · 2006 · International Heart Journal
  100. A Prospective Trial to Evaluate the Safety and Efficacy of Pravastatin for the Treatment of Refractory Chronic Graft-Versus-Host Disease
    Akiko Hori, Yoshinobu Kanda, Susumu Goyama, Yasushi Onishi, Yukiko Komeno, Kinuko Mitani, Yukiko Kishi, Seishi Ogawa, Osamu Imataki, Shigeru Chiba et al. · 2005 · Transplantation